Skip to content
ClinCalc Pro
Menu
CKD — Nutritional Supplement (Very Low Protein Diet)

Ketoanalogues of Essential Amino Acids

Brand names: Ketosteril

Ketoanalogues of essential amino acids are a nitrogen-free amino acid preparation used alongside a low-protein diet in patients with chronic kidney disease to help manage uraemia while maintaining nutrition.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

The keto- and hydroxy-acid analogues are transaminated into their corresponding essential amino acids by incorporating circulating nitrogen, allowing protein synthesis while reducing the production of nitrogenous waste.

Prescribing in practice

  • It must be used together with an adequately energy-supplied low-protein diet and is unsuitable where dietary protein or energy intake cannot be assured.
  • Serum calcium should be monitored, as the preparation contains calcium and hypercalcaemia can occur.
  • It is contraindicated in disorders of amino acid metabolism and in hypercalcaemia.

Monitoring

Monitor serum calcium and overall nutritional and renal parameters during treatment.

Counselling the patient

  • Take with meals and adhere to the prescribed low-protein, adequate-energy diet.
  • Attend dietitian and blood test appointments as arranged.
  • Report symptoms such as nausea, confusion or excessive thirst.

Evidence & guidelines

Ketoanalogue-supplemented low-protein diets are used to help control uraemic symptoms and may slow progression in selected chronic kidney disease patients.

Reference: Garneata et al. NEJM 2016 (VLPD + Ketosteril trial); ERA-EDTA CKD Nutrition Guidelines; SPC Ketosteril; KDOQI Nutrition Guidelines 2020; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.